1996
DOI: 10.1021/jm960062t
|View full text |Cite
|
Sign up to set email alerts
|

Potent, Selective Tetrahydro-β-carboline Antagonists of the Serotonin 2B (5HT2B) Contractile Receptor in the Rat Stomach Fundus

Abstract: A series of potent, selective 5HT2B receptor antagonists has been identified based upon yohimbine, with SAR studies resulting in a 1000-fold increase in 5HT2B receptor affinity relative to the starting structure (-log KBS > 10.0 have been obtained). These high-affinity tetrahydro-beta-carboline antagonists are able to discriminate among the 5HT2 family of serotonin receptors, with members of the series showing selectivities of more than 100-fold versus both the 5HT2A and 5HT2C receptors based upon radioligand … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
73
0

Year Published

1998
1998
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 126 publications
(74 citation statements)
references
References 30 publications
1
73
0
Order By: Relevance
“…LY266070 (1 nM), a selective antagonist of the 5-HT2B receptor (24), reduced by 52% the AA release measured at day 4, whereas it abolished PLA2 activation at day 2 by nearly 100% (Fig. 3).…”
Section: The Activation Of 5-ht2b Receptor Subtypes Increasesmentioning
confidence: 95%
“…LY266070 (1 nM), a selective antagonist of the 5-HT2B receptor (24), reduced by 52% the AA release measured at day 4, whereas it abolished PLA2 activation at day 2 by nearly 100% (Fig. 3).…”
Section: The Activation Of 5-ht2b Receptor Subtypes Increasesmentioning
confidence: 95%
“…8,[13][14][15][16] Therefore, in this study, we used these agents to investigate the involvement of 5-HT 2 receptor subtypes and their intracellular signal transduction pathways in 5-HT-induced hepatocyte DNA synthesis and proliferation in primary cultures of adult rat hepatocytes.…”
mentioning
confidence: 99%
“…1) Previous investigations focused on the effects of b-carboline alkoloids on the central nervous system (CNS). [2][3][4][5][6][7][8][9] Recent reports [10][11][12][13][14][15][16][17] have pointed out b-carbolines as a class of potential antitumor agents, which was discovered to function their antitumor activity through multiple mechanisms, such as intercalating into DNA, 11,18) inhibiting topoisomerase I and II, 13) CDK, [19][20][21] MAPKAP-K2, 22) MK-2, 23) PLK1 24) and kinesin Eg5. 25) Recently, our group investigations [26][27][28][29][30][31] on the synthesis of a variety of b-carboline derivatives and the evaluation of their antitumor activities unraveled that b-carbolines had potent antitumor activities and the activities were correlated to both the planarity of the molecule and the presence of the ring substituents.…”
mentioning
confidence: 99%